Form D · Other Health Care
Franklin BioScience - Penn LLC
Denver, CO · CIK 0001706506
Offering snapshot reported May 11, 2017 · SEC filing
- Reported sold
- $5.66M Indefinite offering
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 13, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2017 | Initial | $5,660,000 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-286557
Source: Form D, filed May 11, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Franklin Bio Science, Llc | Promoter |
| Jason Glickman | Director |
| Bob Pease | Director |
| Andy Weiss | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Franklin Bio Science, Llc 3980 Franklin Street
Denver, CO, 80205
Denver, CO, 80205